InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,158.04
(
0.59%
)
US TECH 100
17,516.68
(
0.56%
)
Dow Jones
38,810.64
(
0.35%
)
Brent Oil
83.41
(
0.34%
)
Bitcoin
64,091.24
(
0.14%
)
Post# of 423985
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

slimhere

Send PM Follow Ignore
Followers 29
Posts 2138
Boards Moderated 0
Alias Born 06/27/2007

slimhere

Re: Pyrrhonian post# 99398

Friday, 02/03/2017 10:17:06 AM

Friday, February 03, 2017 10:17:06 AM

Post# of 423985
It stands to reason that if V is half the drug many here claim, then of course the placebo arm will have more drop outs, once you have a CV event, you're out of the study, or one could look at it as if you, dropped out.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News
InvestorsHub NewsWire

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM

Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM

Start posting your company's news
Only $200 per official company press release!